Trial Profile
A Safety and Efficacy Study of Fixed-Combination Bimatoprost and Brimonidine in Chronic Glaucoma or Ocular Hypertension
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 02 Feb 2015
Price :
$35
*
At a glance
- Drugs Bimatoprost/brimonidine (Primary) ; Bimatoprost; Brimonidine
- Indications Glaucoma; Ocular hypertension
- Focus Therapeutic Use
- Sponsors Allergan
- 18 Jan 2014 New trial record